The guideline 'Recurrent Miscarriage' (first revision) of the Dutch society for obstetrics and gynaecology
Goddijn, M., van den Boogaard, E., Steepers, E.A., Erwich, J.J., Macklon, N. and Steegers-Theunissen, R.P. (2008) The guideline 'Recurrent Miscarriage' (first revision) of the Dutch society for obstetrics and gynaecology. Nederlands Tijdschrift voor Geneeskunde , 152, (30), 1665-1670.
Full text not available from this repository.
In 2007, the Dutch Society for Obstetrics and Gynaecology issued a revised version of the 1999 guideline on recurrent miscarriage. --The new guideline was developed according to the principles of evidence-based guideline development and includes levels of evidence. --The guideline contains recommendations for effective diagnosis and treatment and explicitly mentions certain diagnostic tests and treatments that should be avoided. --After a thorough investigation of a couples'-history, the type of diagnostic tests that should be offered to the couple can be determined. Patients with a low risk of having cytogenetic abnormalities or thrombophilia may be excluded from parental karyotyping and thrombophilia screening, respectively. --Women with confirmed antiphospholipid antibody syndrome should be offered anticoagulation treatment before and during subsequent pregnancies. --Effective therapy for unexplained recurrent miscarriage is lacking. However, the probability of a successful future pregnancy is high. This probability can be estimated based on the number of previous miscarriages and maternal age.
|Subjects:||R Medicine > R Medicine (General)|
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Developmental Origins of Health and Disease
|Date Deposited:||06 May 2010 08:23|
|Last Modified:||02 Mar 2012 13:14|
|Contributors:||Goddijn, M. (Author)
van den Boogaard, E. (Author)
Steepers, E.A. (Author)
Erwich, J.J. (Author)
Macklon, N. (Author)
Steegers-Theunissen, R.P. (Author)
|Date:||26 July 2008|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)